Clinical Report: Elevated Prefrontal TGF-β1 and Cognitive Dysfunction in Rats

Overview

This study demonstrates that a 10-day repetitive sleep deprivation model in rats leads to cognitive impairment and increased anxiety-like behavior, alongside elevated prefrontal TGF-β1 levels.

Background

Chronic fatigue syndrome (CFS) is characterized by persistent fatigue and cognitive dysfunction, affecting millions globally. Understanding the underlying mechanisms, particularly the role of cytokines like TGF-β1, is crucial for developing targeted interventions. This study explores the relationship between TGF-β1 dysregulation and cognitive impairment in a rat model of fatigue.

Data Highlights

Key Findings

• Fatigue group showed significantly increased anxiety-like behavior in the open field test.
• Spontaneous alternation rates were markedly reduced in the Y-maze test for the fatigue group compared to controls.
• Prefrontal cortical TGF-β1 levels were elevated in fatigued rats.
• No significant differences in peripheral or striatal TGF-β1 levels between groups.
• The model induced cognitive impairment alongside anxiety-like behavior.

Clinical Implications

The elevation of prefrontal TGF-β1 in the context of cognitive deficits may provide insights into the neurobiological underpinnings of chronic fatigue.

Conclusion

The findings highlight the involvement of central TGF-β1 signaling in cognitive dysfunction associated with chronic fatigue.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Clinical Overview of ME/CFS | ME/CFS | CDC
6. Frontiers | Cognitive assessment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a cognitive substudy of the multi-site clinical assessment of ME/CFS (MCAM)
7. Cytokine signature associated with disease severity in chronic fatigue syndrome patients - PMC
8. Clinical Overview of ME/CFS | ME/CFS | CDC
9. Frontiers | Cognitive assessment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a cognitive substudy of the multi-site clinical assessment of ME/CFS (MCAM)
10. Cytokine signature associated with disease severity in chronic fatigue syndrome patients - PMC